z-logo
Premium
Percutaneous suture‐mediated closure of femoral access sites deployed through the procedure sheath: Initial clinical experience with a novel vascular closure device
Author(s) -
Eggebrecht Holger,
Naber Christoph,
Woertgen Uta,
Ringe Sonia,
Konorza Thomas F.M.,
Schmermund Axel,
von Birgelen Clemens,
Haude Michael,
Kroeger Knut,
Erbel Raimund,
Baumgart Dietrich
Publication year - 2003
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.10472
Subject(s) - medicine , vascular closure device , percutaneous , hemostasis , surgery , femoral vein , femoral artery , fibrous joint , cardiac catheterization , complication , closure (psychology) , market economy , economics
The objective of this study was to assess the initial safety and feasibility of a novel suture‐mediated device for closure of femoral access sites immediately after diagnostic or interventional cardiac catheterization. In a prospective study, 150 patients (mean age, 61.5 years; 109 male) underwent femoral access closure with a novel suture closure device (Superstitch, Sutura) immediately after diagnostic (n = 106) or interventional (n = 44) catheterization procedures, independently of the coagulation status. All patients were monitored for 24 hr after the procedure. The closure device was successfully deployed in 92% of patients. Immediate hemostasis was achieved in 77% of patients with no differences between patients undergoing diagnostic catheterization or coronary interventions (79% vs. 73%; P = 0.659). After 2 min of additional light manual compression, hemostasis was achieved in 92% of patients. There was one major complication requiring vascular surgery (0.7%). The novel suture closure device is a safe and effective device that allows for immediate closure of femoral puncture sites after both diagnostic and interventional procedures with a low rate of major complications. Cathet Cardiovasc Intervent 2003;58:313‐321. © 2003 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom